Stempoint Capital’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47M | Sell |
1,143,677
-46,902
| -4% | -$142K | 1.11% | 28 |
|
|
2025
Q1 | $5.07M | Buy |
1,190,579
+858,185
| +258% | +$3.66M | 1.62% | 26 |
|
|
2024
Q4 | $1.76M | Sell |
332,394
-610,463
| -65% | -$3.22M | 0.44% | 42 |
|
|
2024
Q3 | $1.73M | Sell |
942,857
-41,256
| -4% | -$75.5K | 0.52% | 40 |
|
|
2024
Q2 | $2.05M | Buy |
984,113
+815,671
| +484% | +$1.7M | 0.6% | 38 |
|
|
2024
Q1 | $675K | Buy |
+168,442
| New | +$675K | 0.18% | 45 |
|